LDVCX
Price
$25.64
Change
-$0.44 (-1.69%)
Updated
Jun 13 closing price
Net Assets
104.1M
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

LDVCX vs RGEBX

Header iconLDVCX vs RGEBX Comparison
Open Charts LDVCX vs RGEBXBanner chart's image
AXS FTSE Vntr Cptl RetTrckr C
Price$25.64
Change-$0.44 (-1.69%)
VolumeN/A
Net Assets104.1M
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
LDVCX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LDVCX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LDVCX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. LDVCX (104M). LDVCX (0.00) and RGEBX (0.00) have matching dividends . LDVCX was incepted earlier than RGEBX: LDVCX (10 years) vs RGEBX (11 years). LDVCX (2.72) is less costly to investors than RGEBX (1.09). LDVCX is a more actively managed with annual turnover of: 29.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than LDVCX: RGEBX (250) vs LDVCX (2500). LDVCX annual gain was more profitable for investors over the last year : 30.68 vs. RGEBX (7.68). RGEBX return over 5 years is better than : 45.42 vs. LDVCX (17.32).
LDVCXRGEBXLDVCX / RGEBX
Total Expense Ratio2.501.09229%
Annual Report Gross Expense Ratio2.721.09250%
Fund Existence10 years11 years-
Gain YTD12.1124.829251%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets104M306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year30.687.68400%
Returns for 3 years118.0351.01231%
Returns for 5 years17.3245.4238%
Returns for 10 yearsN/A65.87-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd